Singapore markets closed
  • Straits Times Index

    3,292.73
    +2.24 (+0.07%)
     
  • S&P 500

    4,080.11
    +122.48 (+3.09%)
     
  • Dow

    34,589.77
    +737.24 (+2.18%)
     
  • Nasdaq

    11,468.00
    +484.22 (+4.41%)
     
  • BTC-USD

    17,180.03
    +351.38 (+2.09%)
     
  • CMC Crypto 200

    407.17
    +6.47 (+1.61%)
     
  • FTSE 100

    7,582.63
    +9.58 (+0.13%)
     
  • Gold

    1,802.00
    +42.10 (+2.39%)
     
  • Crude Oil

    82.11
    +1.56 (+1.94%)
     
  • 10-Yr Bond

    3.5830
    -0.1200 (-3.24%)
     
  • Nikkei

    28,226.08
    +257.09 (+0.92%)
     
  • Hang Seng

    18,736.44
    +139.21 (+0.75%)
     
  • FTSE Bursa Malaysia

    1,491.51
    +2.71 (+0.18%)
     
  • Jakarta Composite Index

    7,020.80
    -60.51 (-0.85%)
     
  • PSE Index

    6,734.99
    -45.79 (-0.68%)
     

This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year. Here are three reasons to consider InMode as a long-term growth stock for your portfolio. InMode designs and builds non-invasive medical equipment for cosmetic procedures like face and body contouring, hair removal, and women's wellness.